The article discusses the prevalence of copycats in the technology field in the 21st century. Topics discussed include the high technology companies, such as Apple, Google and Microsoft, all having similar product portfolios, the rules regarding copyrights and patents as of 2016 and the ways in which copycats hinder innovation, according to the author. Also discussed is a suggestion to adopt the pharmaceutical sector's rule of waiting 20 years before generic copies are allowed in the market.
© 2001-2025 Fundación Dialnet · Todos los derechos reservados